RSS Feeds
Corticosteroids for Septic Shock
- Peter C. Minneci, MD;
- Katherine J. Deans, MD;
- Steven M. Banks, PhD;
- Peter Q. Eichacker, MD; and
- Charles Natanson, MD
- From National Institutes of Health, Bethesda, MD 20892.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
The editorial by Dr. Luce (1) accompanying our meta-analysis examining clinical trials of low-dose steroid therapy in sepsis (2) raised concerns …
This 100-word excerpt has been provided in the absence of an abstract.
